Clinical Trials Directory

Trials / Sponsors / Nasser Hanna, M.D.

Nasser Hanna, M.D.

Academic / Other · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedSingle Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary
Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Adenocarcinoma of the Lung, Lung Cancer
Phase 22017-01-27
TerminatedPembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Germ Cell Neoplasms, Testicular Neoplasms, Non Seminomatous Germ Cell Tumors
Phase 22016-01-01
CompletedConsolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 22015-03-09
TerminatedCisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell L
Non-Small Cell Lung Cancer
Phase 1 / Phase 22007-06-01
CompletedErlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
Lung Cancer
Phase 22006-08-01
CompletedCetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcin
Esophageal Cancer
Phase 22006-04-01
CompletedPemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 1 / Phase 22005-05-01
CompletedCisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 32002-02-01